aTYR PHARMA (ATYR) Other Operating Expenses (2023 - 2026)
aTYR PHARMA's (ATYR) quarterly Other Operating Expenses came in at -$15.2 million in Q1 2026, up 23.18% YoY from -$12.3 million in Q1 2025, and up 81.99% on a QoQ basis from -$84.2 million in Q4 2025.
aTYR PHARMA (ATYR) Other Operating Expenses (2023 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has 4 years of Other Operating Expenses data on file, last reported at -$15.2 million in Q1 2026.
- Quarterly Other Operating Expenses rose 23.18% year-over-year to -$15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107.1 million (down 494.58% YoY) and the FY2025 annual result came in at -$95.1 million, down 733.63% from the prior year.
- Other Operating Expenses grew to -$15.2 million in Q1 2026, from -$84.2 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $52.4 million in Q4 2024 to a low of -$84.2 million in Q4 2025.
- A 4-year average of -$16.1 million and a median of -$9.5 million in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses soared 187.71% — and 2025, when it slumped 260.5%.
- Tracing ATYR's Other Operating Expenses over 4 years: stood at -$59.8 million in 2023, then soared by 187.71% to $52.4 million in 2024, then tumbled by 260.5% to -$84.2 million in 2025, then soared by 81.99% to -$15.2 million in 2026.
- The last three Other Operating Expenses figures came in at -$15.2 million (Q1 2026), -$84.2 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | aTYR PHARMA | 49.54 Mn | -7.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.23 Mn |
| Mar 31, 2026 | -15.16 Mn |
| Dec 31, 2025 | -84.17 Mn |
| Sep 30, 2025 | -3.89 Mn |
| Jun 30, 2025 | -3.93 Mn |
| Mar 31, 2025 | -19.73 Mn |
| Dec 31, 2024 | 52.44 Mn |
| Sep 30, 2024 | -2.80 Mn |
| Jun 30, 2024 | -2.76 Mn |
| Mar 31, 2024 | -20.94 Mn |
| Dec 31, 2023 | -59.79 Mn |